Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis.

Baert L, Benkhoucha M, Popa N, Ahmed MC, Manfroi B, Boutonnat J, Sturm N, Raguenez G, Tessier M, Casez O, Marignier R, Ahmadi M, Broisat A, Ghezzi C, Rivat C, Sonrier C, Hahne M, Baeten D, Vives RR, Lortat-Jacob H, Marche PN, Schneider P, Lassmann HP, Boucraut J, Lalive PH, Huard B.

Ann Neurol. 2019 Mar;85(3):406-420. doi: 10.1002/ana.25415. Epub 2019 Feb 4.

PMID:
30635946
2.

Transmembrane TNF and Partially TNFR1 Regulate TNFR2 Expression and Control Inflammation in Mycobacterial-Induced Pleurisy.

Uysal H, Chavez-Galan L, Vesin D, Blaser G, Benkhoucha M, Ryffel B, Quesniaux VFJ, Garcia I.

Int J Mol Sci. 2018 Jul 4;19(7). pii: E1959. doi: 10.3390/ijms19071959.

3.

Transmembrane Tumor Necrosis Factor Controls Myeloid-Derived Suppressor Cell Activity via TNF Receptor 2 and Protects from Excessive Inflammation during BCG-Induced Pleurisy.

Chavez-Galan L, Vesin D, Uysal H, Blaser G, Benkhoucha M, Ryffel B, Quesniaux VFJ, Garcia I.

Front Immunol. 2017 Aug 25;8:999. doi: 10.3389/fimmu.2017.00999. eCollection 2017.

4.

Identification of a novel population of highly cytotoxic c-Met-expressing CD8+ T lymphocytes.

Benkhoucha M, Molnarfi N, Kaya G, Belnoue E, Bjarnadóttir K, Dietrich PY, Walker PR, Martinvalet D, Derouazi M, Lalive PH.

EMBO Rep. 2017 Sep;18(9):1545-1558. doi: 10.15252/embr.201744075. Epub 2017 Jul 27.

5.

Activation of human B cells negatively regulates TGF-β1 production.

Molnarfi N, Bjarnadóttir K, Benkhoucha M, Juillard C, Lalive PH.

J Neuroinflammation. 2017 Jan 19;14(1):13. doi: 10.1186/s12974-017-0798-5.

6.

B cell-derived transforming growth factor-β1 expression limits the induction phase of autoimmune neuroinflammation.

Bjarnadóttir K, Benkhoucha M, Merkler D, Weber MS, Payne NL, Bernard CCA, Molnarfi N, Lalive PH.

Sci Rep. 2016 Oct 6;6:34594. doi: 10.1038/srep34594.

7.

Novel Cell-Penetrating Peptide-Based Vaccine Induces Robust CD4+ and CD8+ T Cell-Mediated Antitumor Immunity.

Derouazi M, Di Berardino-Besson W, Belnoue E, Hoepner S, Walther R, Benkhoucha M, Teta P, Dufour Y, Yacoub Maroun C, Salazar AM, Martinvalet D, Dietrich PY, Walker PR.

Cancer Res. 2015 Aug 1;75(15):3020-31. doi: 10.1158/0008-5472.CAN-14-3017. Epub 2015 Jun 26.

8.

Hepatocyte growth factor: A regulator of inflammation and autoimmunity.

Molnarfi N, Benkhoucha M, Funakoshi H, Nakamura T, Lalive PH.

Autoimmun Rev. 2015 Apr;14(4):293-303. doi: 10.1016/j.autrev.2014.11.013. Epub 2014 Dec 1. Review.

PMID:
25476732
9.

Hepatocyte growth factor limits autoimmune neuroinflammation via glucocorticoid-induced leucine zipper expression in dendritic cells.

Benkhoucha M, Molnarfi N, Dunand-Sauthier I, Merkler D, Schneiter G, Bruscoli S, Riccardi C, Tabata Y, Funakoshi H, Nakamura T, Reith W, Santiago-Raber ML, Lalive PH.

J Immunol. 2014 Sep 15;193(6):2743-52. doi: 10.4049/jimmunol.1302338. Epub 2014 Aug 11.

10.

The neurotrophic hepatocyte growth factor induces protolerogenic human dendritic cells.

Molnarfi N, Benkhoucha M, Juillard C, Bjarnadóttir K, Lalive PH.

J Neuroimmunol. 2014 Feb 15;267(1-2):105-10. doi: 10.1016/j.jneuroim.2013.12.004. Epub 2013 Dec 11.

PMID:
24367900
11.

The neurotrophic hepatocyte growth factor attenuates CD8+ cytotoxic T-lymphocyte activity.

Benkhoucha M, Molnarfi N, Schneiter G, Walker PR, Lalive PH.

J Neuroinflammation. 2013 Dec 17;10:154. doi: 10.1186/1742-2094-10-154.

12.

TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3+ Treg cells.

Lalive PH, Benkhoucha M, Tran NL, Kreutzfeldt M, Merkler D, Santiago-Raber ML.

Eur J Immunol. 2014 Jan;44(1):46-57. doi: 10.1002/eji.201242985. Epub 2013 Oct 1.

13.

Nogo-A downregulation improves insulin secretion in mice.

Bonal CB, Baronnier DE, Pot C, Benkhoucha M, Schwab ME, Lalive PH, Herrera PL.

Diabetes. 2013 May;62(5):1443-52. doi: 10.2337/db12-0949. Epub 2012 Dec 28.

14.

Interferon-β induces hepatocyte growth factor in monocytes of multiple sclerosis patients.

Molnarfi N, Benkhoucha M, Bjarnadóttir K, Juillard C, Lalive PH.

PLoS One. 2012;7(11):e49882. doi: 10.1371/journal.pone.0049882. Epub 2012 Nov 14.

15.

IgG glycan hydrolysis by EndoS inhibits experimental autoimmune encephalomyelitis.

Benkhoucha M, Molnarfi N, Santiago-Raber ML, Weber MS, Merkler D, Collin M, Lalive PH.

J Neuroinflammation. 2012 Sep 3;9:209.

16.

Selective APRIL blockade delays systemic lupus erythematosus in mouse.

Huard B, Tran NL, Benkhoucha M, Manzin-Lorenzi C, Santiago-Raber ML.

PLoS One. 2012;7(2):e31837. doi: 10.1371/journal.pone.0031837. Epub 2012 Feb 15.

17.

Antibody response in MOG(35-55) induced EAE.

Lalive PH, Molnarfi N, Benkhoucha M, Weber MS, Santiago-Raber ML.

J Neuroimmunol. 2011 Dec 15;240-241:28-33. doi: 10.1016/j.jneuroim.2011.09.005. Epub 2011 Oct 10.

PMID:
21993076
18.

Glatiramer acetate in the treatment of multiple sclerosis: emerging concepts regarding its mechanism of action.

Lalive PH, Neuhaus O, Benkhoucha M, Burger D, Hohlfeld R, Zamvil SS, Weber MS.

CNS Drugs. 2011 May;25(5):401-14. doi: 10.2165/11588120-000000000-00000. Review.

19.

Evidence for a repertoire of functional untolerized CD4+ T cells specific for melanoma-associated antigens.

Huber V, Benkhoucha M, Huard B.

Scand J Immunol. 2011 Jul;74(1):80-6. doi: 10.1111/j.1365-3083.2011.02548.x.

20.

Repetitive pertussis toxin promotes development of regulatory T cells and prevents central nervous system autoimmune disease.

Weber MS, Benkhoucha M, Lehmann-Horn K, Hertzenberg D, Sellner J, Santiago-Raber ML, Chofflon M, Hemmer B, Zamvil SS, Lalive PH.

PLoS One. 2010 Dec 30;5(12):e16009. doi: 10.1371/journal.pone.0016009.

21.

MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity.

Irla M, Küpfer N, Suter T, Lissilaa R, Benkhoucha M, Skupsky J, Lalive PH, Fontana A, Reith W, Hugues S.

J Exp Med. 2010 Aug 30;207(9):1891-905. doi: 10.1084/jem.20092627. Epub 2010 Aug 9.

22.

Hepatocyte growth factor inhibits CNS autoimmunity by inducing tolerogenic dendritic cells and CD25+Foxp3+ regulatory T cells.

Benkhoucha M, Santiago-Raber ML, Schneiter G, Chofflon M, Funakoshi H, Nakamura T, Lalive PH.

Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6424-9. doi: 10.1073/pnas.0912437107. Epub 2010 Mar 23.

23.

Glatiramer acetate increases IL-1 receptor antagonist but decreases T cell-induced IL-1beta in human monocytes and multiple sclerosis.

Burger D, Molnarfi N, Weber MS, Brandt KJ, Benkhoucha M, Gruaz L, Chofflon M, Zamvil SS, Lalive PH.

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4355-9. doi: 10.1073/pnas.0812183106. Epub 2009 Mar 2.

24.

Glatiramer acetate treatment does not modify the clinical course of (NZB x BXSB)F1 lupus murine model.

Borel P, Benkhoucha M, Weber MS, Zamvil SS, Santiago-Raber ML, Lalive PH.

Int Immunol. 2008 Oct;20(10):1313-9. doi: 10.1093/intimm/dxn086. Epub 2008 Aug 6.

PMID:
18687587
25.

Interferon-beta induces brain-derived neurotrophic factor in peripheral blood mononuclear cells of multiple sclerosis patients.

Lalive PH, Kantengwa S, Benkhoucha M, Juillard C, Chofflon M.

J Neuroimmunol. 2008 Jul 15;197(2):147-51. doi: 10.1016/j.jneuroim.2008.04.033. Epub 2008 Jun 13.

PMID:
18555540
26.

Inhibition of naive Th1 CD4+ T cells by glatiramer acetate in multiple sclerosis.

Kantengwa S, Weber MS, Juillard C, Benkhoucha M, Fellay B, Zamvil SS, Gougeon ML, Chofflon M, Lalive PH.

J Neuroimmunol. 2007 Apr;185(1-2):123-9. Epub 2007 Feb 15.

PMID:
17306890
27.

[Apropos of slimming cures by RP-8,228 in a psychiatric hospital].

de VERBIZIER, GUILLON A, BENKHOUCHA M.

Toulouse Med. 1962 Apr;63:437-43. French. No abstract available.

PMID:
13925381

Supplemental Content

Loading ...
Support Center